Facetten
Zugriff
Einrichtung
Medientyp
- Text 3
Karte
Erscheinungsjahr
Autor/in
- Burdelski, Christoph
- Karakas, Mahir
- Akin, Ibrahim 2
- Jarczak, Dominik 2
- Kluge, Stefan 2
- alle zeigen
Sprache
- Englisch 3
3 Einträge gefunden
-
Single-dose of adrecizumab versus placebo in acute cardiogenic shock (ACCOST-HH): an investigator-initiated, randomised, double-blinded, placebo-controlled, multicentre trial
- Karakas, Mahir
- Akin, Ibrahim
- Burdelski, Christoph
- Clemmensen, Peter
- Grahn, Hanno
- Jarczak, Dominik
- Keßler, Mirjam
-
MR-proAdrenomedullin as a predictor of renal replacement therapy in a cohort of critically ill patients with COVID-19
- Roedl, Kevin
- Jarczak, Dominik
- Fischer, Marlene
- Haddad, Munif
- Boenisch, Olaf
- de Heer, Geraldine
- Burdelski, Christoph
-
The ACCOST-HH Trial:An investigator-initiated trial, the placebo-controlled, double-blind, multi-centre, randomized trial to assess the efficacy and safety of the antibody AdreCizumab (HAM8101) against plaCebO in SubjecTs witH cardiogenic sHock, (ACCOST-HH) in progress is discussed
- Skurk, Carsten
- Rottbauer, Wolfgang
- Kessler, Mirjam
- Akin, Ibrahim
- Kluge, Stefan
- Burdelski, Christoph
- Blankenberg, Stefan